SLI
2.017,11
PKT
-5,54
PKT
-0,27
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.04.18 | Zurich Insurance Neutral | UBS AG | |
| 27.04.18 | Novartis Neutral | UBS AG | |
| 27.04.18 | Roche Neutral | Credit Suisse Group | |
| 27.04.18 | UBS verkaufen | Barclays Capital | |
| 27.04.18 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.04.18 | Roche overweight | JP Morgan Chase & Co. | |
| 26.04.18 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.04.18 | Roche Hold | Kepler Cheuvreux | |
| 26.04.18 | Roche kaufen | DZ BANK | |
| 26.04.18 | UBS buy | UBS AG | |
| 26.04.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.04.18 | UBS buy | Goldman Sachs Group Inc. | |
| 26.04.18 | UBS kaufen | Morgan Stanley | |
| 26.04.18 | ams-OSRAM buy | Deutsche Bank AG | |
| 26.04.18 | Roche overweight | JP Morgan Chase & Co. | |
| 26.04.18 | UBS overweight | JP Morgan Chase & Co. | |
| 25.04.18 | UBS Hold | S&P Capital IQ | |
| 25.04.18 | UBS overweight | Morgan Stanley | |
| 25.04.18 | UBS Outperform | BNP PARIBAS | |
| 25.04.18 | ams-OSRAM overweight | JP Morgan Chase & Co. | |
| 25.04.18 | UBS Underweight | Barclays Capital | |
| 25.04.18 | ams-OSRAM Outperform | Credit Suisse Group | |
| 25.04.18 | UBS buy | Deutsche Bank AG | |
| 24.04.18 | Zurich Insurance buy | Citigroup Corp. | |
| 24.04.18 | Nestlé Equal weight | Barclays Capital | |
| 24.04.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 24.04.18 | UBS Hold | Société Générale Group S.A. (SG) | |
| 24.04.18 | UBS overweight | Morgan Stanley | |
| 24.04.18 | UBS Outperform | Credit Suisse Group | |
| 24.04.18 | UBS overweight | JP Morgan Chase & Co. | |
| 23.04.18 | Swiss Re Hold | Commerzbank AG | |
| 23.04.18 | UBS Hold | S&P Capital IQ | |
| 23.04.18 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 23.04.18 | Givaudan Neutral | UBS AG | |
| 23.04.18 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 23.04.18 | UBS Outperform | Credit Suisse Group | |
| 23.04.18 | UBS overweight | JP Morgan Chase & Co. | |
| 23.04.18 | UBS buy | Baader Bank | |
| 23.04.18 | UBS Neutral | Goldman Sachs Group Inc. | |
| 23.04.18 | Roche overweight | JP Morgan Chase & Co. |